Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Debt / NOTE 1.500% 9/1
-
Number of holders
-
13
-
Total 13F principal, excl. options
-
264,421,591
-
Principal change
-
+4,972,000
-
Total reported value, excl. options
-
$309,275,303
-
Value change
-
-$20,168,580
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$1.12
Significant Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q4 2024
15 filings reported holding 69366JAD3 - PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q4 2024.
PTC THERAPEUTICS INC - NOTE 1.500% 9/1 has 13 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $264,421,591 of principal
.
Largest 10 bondholders include FRANKLIN RESOURCES INC ($61,000,000 of principal), Linden Advisors LP ($49,979,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($40,370,000 of principal), D. E. Shaw & Co., Inc. ($35,984,000 of principal), DeepCurrents Investment Group LLC ($30,151,000 of principal), Voya Investment Management LLC ($16,500,000 of principal), WHITEBOX ADVISORS LLC ($12,000,000 of principal), CSS LLC/IL ($6,000,000 of principal), ARISTEIA CAPITAL, L.L.C. ($6,000,000 of principal), and Aequim Alternative Investments LP ($3,000,000 of principal).
This table shows the top 13 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.